Chemotherapy: Open Access
Open Access

International Conference on Antimicrobial Agents and Chemotherapy

August 04-06, 2015 Valencia, Spain

Posters-Accepted Abstracts

• Fuse binding protein1 (FBP1) as antagonist of p53: A potential host target for drug development

  Virendra N Pandey

  PDF HTML

• Drug development targeting cancer stem cells

  Angel G Martin

  PDF HTML

• Screen detected symptoms of breast cancer and its relation with program performance indicators in Finland

  Deependra Singh

  PDF HTML

• The effect of various forms of social support on quality of life and relationship of women with breast cancer and the differences compared to the general female population

  Dimitrakopoulou Veronika

  PDF HTML

• Isolation and characterization of circulating tumor cells (CTCs) in triple negative breast cancer patients in response to chemotherapy

  Galatea Kallergi

  PDF HTML

• After 30 years of discovery of the EPR effect for tumor drug delivery, revolution cancer therapy after overcoming problems

  Hiroshi Maeda

  PDF HTML

• Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines

  Jan Stenvang

  PDF HTML

• Protontherapy vs. carbon ion therapy: Advantages, disadvantages and similarities

  Marcos d’Avila Nunes

  PDF HTML

• Expression of the Human Papilloma Virus (HPV): Comparative assessment in peripheral blood and retinoblastomas

  Maria Tereza Cartaxo Muniz

  PDF HTML

• Emerging concepts in breast cancer neoadjuvant chemotherapy

  Nina Radosevic-Robin and Frederique Penault-Llorca

  PDF HTML

• HSP90 and tyrosine kinase inhibitors: A synergistic combination for combating cancer?

  Thomas Prince

  PDF HTML

• Dichloroacetate (DCA) as an oncology chemotherapeutic agent? What’s all the hype and is it warranted? Complete with clinical outcomes

  Sherry A Bradford

  PDF HTML